Professor Jacob George has started his role as chief medical and scientific officer (CMSO) at the Medicines and Healthcare products Regulatory Agency (MHRA).

Professor George will lead the Agency’s science strategy and will oversee the MHRA’s scientific, research and innovation activities.

The CMSO role supports the MHRA’s commitment to scientific excellence and innovation, supporting the UK’s life sciences ambitions while safeguarding patient safety.

Professor George brings experience from his time as Professor of Cardiovascular Medicine and Therapeutics at the University of Dundee and as a consultant physician in NHS Tayside.

He is also a member of the Delivery Group and Management Board for the Innovative Licensing and Access Pathway (ILAP), the current Co-Chair on the National Institute of Health Research (NIHR) Capital Investment Funding Committee and has been Senior Health Technology Advisor to NICE.

Professor Jacob George said: “I am delighted to be joining the MHRA at such an important time for science and regulation.

“The Agency plays a vital role in protecting patient safety while supporting innovation, and I look forward to working with colleagues and partners across the UK to strengthen scientific excellence and public trust.”

Lawrence Tallon, chief executive of the MHRA, said: “We are delighted to welcome Professor Jacob George as our Chief Medical and Scientific Officer. Jacob’s expertise and leadership in science and innovation will empower us to continue to set new standards as a world-class regulator, safeguarding public health and accelerating access to medicines and medical devices across all four nations of the UK.”